DIANE YIRENKYI-GEORGE: Open Payments
NPI 1952758476 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 44 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $130 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $357 |
| Alkermes, Inc. | 6 | $129 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $119 |
| Lundbeck LLC | 3 | $65 |
| ABBVIE INC. | 2 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $36 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Corium, LLC | 1 | $20 |
| Tris Pharma Inc | 1 | $18 |
Products named: REXULTI, ARISTADA, CAPLYTA, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, ABILIFY MAINTENA, INGREZZA.
Industry payments across MI — which companies pay providers there.
